REVENUES=EAPH INDISPUTABLE, RELIABLE, ACCURATE REAL FACTS as PROMISED by EAPH: EAPH’s Progress and Advancements, after years of selection, discussions and negotiations, many JV’s have now been finalized and will provide many EAPH REVENUE STREAMS for years to come;
EAPH/BIG PHARMA JV’s: After consummating the Bayer/Gedeon Richter/Windsor Pharmaceutical joint ventures the EAPH women’s health products distribution and sales worldwide will provide royalties/revenue streams for years to come.
EAPH/ALLIANCE JV: After receiving all required Canadian exemptions/approvals for a marijuana grow facility, are starting the engineering and construction of GREENHOUSES for both Medical Marijuana and Recreational Marijuana cultivation, production and sales worldwide on their 45 acre fully owned parcel of land for the cultivation, production and sale of medical marijuana to the cannabis industry, and will give Easton Pharmaceuticals a strong position into the pharmaceutical production/distribution/sales of Cannabis/Marijuana sales worldwide for years. Easton and partner Alliance are receiving quotes towards the construction of a facility for the cultivation and growing of recreational marijuana, expected to commence in the second to third quarter of 2018. The Easton / Alliance property has received an independent valuation of over $8,000,000 CDN. This also provides Easton with an ownership interest in a 135 acre property and a 20% to 70% ownership interest in various businesses operating on the land located in the township of Georgina in the Municipality of North York, Ontario, Easton has been notified that operations on the aggregate business of the property from its previously announced $6,000,000 CDN contract with a well-known local construction company is days away from commencing operations and the receipt of its first payment. The property located at 6017 Smith Blvd., Georgina Township, has 90 acres zoned M3 industrial with the remaining 45 acres zoned as agricultural. Several millions of dollars in equipment have been ordered and are expected to be delivered to the property within days. Once delivered, operations will commence which should then allow for additional contracts currently under negotiations to close. In addition to the marijuana facility, Easton and its partner Alliance Group anticipate the aggregate contracts to generate over $6,000,000 in revenues during its first year of operations and expected to grow to $20,000,000 in gross revenues in its second year. However, with negotiations underway for other contracts, these revenue projections could double.
EAPH/iBliss acquisition is now being focused on for management and expansion along with a second ecig company potential acquisition in the country of ENGLAND.
EAPH CURRENT REVENUE STREAMS:
EAPH/ALLIANCE JV – Marijuana Greenhouses/Grower/Producer/Sales
EAPH/ALLIANCE JV – Construction/Aggregate Sales - 6M +
EAPH/BMV - Gedeon Richter Big Pharma JV – Gynofit – South America
EAPH/BMV - Gedeon Richter Big Pharma JV – AS Sense – South America
EAPH/BMV - Bayer Pharma Big Pharma JV – VS-Sense – Mexico/South America
EAPH/Windsor Pharma – VS Sense – AL Sense – Central America/Carribean
EAPH/iBliss – International /Vapor/Cannabis Products/Sales
EAPH/Health Products – Skin Renouha, Nauseasol, Kenestrin Gel, Viorra.
EAPH POTENTIAL ADDITIONAL FUTURE REVENUE STREAMS:
EAPH/VAPE JV (ENGLAND) – International /Vapor/Cannabis Products/Sales
EAPH/AMFE – Potential JV, Additional EAPH Investment in AMFIL
EAPH/Cancer Drugs – Xlive – Docetael – Pacletaxel
EAPH/Topical Drug Delivery Formulation Gels
EAPH/Other Future Big Pharma and Worldwide Marijuana JV’s
